This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Constellation Brands Inc. shares rose 1% in premarket trades Thursday after it said its first-quarter net income increased to $389.5 million, or $2.06 a share, from a loss of $908.1 million, or $4.74 a share, in the year-ago quarter. Adjusted profit was $2.90 a share excluding losses of 24 cents a share from its investment in cannabis company Canopy Growth Corp. . Sales at the wine, spirits and beer maker rose to $2.36 billion from $2.03 billion. Analysts expected Constellation Brands to earn $2.52 a share on revenue of $2.17 billion, according to FactSet data. Looking ahead, Constellation Brands expects adjusted 2022 profit of $11.20 to $11.50 a share, compared to the analyst view of $11.08 a share. Constellation booked a GAAP loss of $165 million for Canopy Growth in the quarter and said it's recognized a $556 million unrealized net loss since its initial Canopy investment in Canopy in November, 2017. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news......»»

Walgreens Boots Alliance Inc. reported fiscal third-quarter net income totaling $289 million, or 33 cents per share, down from $1.197 billion, or $1.38 per share, last year. Adjusted EPS of 96 cents beat the FactSet consensus for 92 cents. Sales of $32.60 billion were down from $34.03 billion last year and ahead of the FactSet consensus for $32.06 billion. U.S. comparable retail sales were up 2.4%, excluding tobacco. Walgreens administered 4.7 million Covid vaccines and 3.9 million tests during the quarter. The Walgreens Health segment of the business, which includes VillageMD, a primary healthcare company, saw a 65% pro forma sales increase year-over-year. Walgreens announced this week that, after a strategic review, it will keep the Boots business. Walgreens continues to forecast full-year adjusted EPS growth in the low-single digits. The FactSet consensus is for EPS of $5.04, implying an increase of 2.6%. Walgreens stock fell 1.6% in Thursday premarket trading and is down 21.6% for the year to date. The S&P 500 index is down nearly 20% for 2022 so far.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news......»»

Pfizer Inc. said Thursday that it has submitted a New Drug Application (NDA) for COVID-19 treatment pills PAXLOVID for patients at high risk for progression to severe illness. PAXLOVID has previously been granted Emergency Use Authorization (EUA) for treatment of mild-to-moderate COVID-19. The drug maker said the NDA submission provides longer-term follow-up data needed for potential approval. "Data from our clinical development program, coupled with the more than 1.7 million patients around the world who have been prescribed our oral treatment to date, reinforce PAXLOVID as an important treatment option for mild-to-moderate COVID-19 in patients at greater risk of progression to severe symptoms, regardless of vaccination status," said Pfizer Chief Executive Albert Bourla. The stock, which slipped 0.6% in premarket trading, has lost 13.7% year to date through Wednesday, while the S&P 500 has climbed 19.9%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news......»»

Seemingly every asset has dropped this year -- and the one that hasn't will get crushed by a recession, a strategist says......»»

Acuity Brands Inc. reported Thursday fiscal third-quarter profit that rose well above expectations, amid strength in its lighting and lighting controls business. The lighting company's stock was still inactive in premarket trading. Net income for the quarter to May 31 rose to $105.7 million, or $3.07 a share, from $85.7 million, or $2.37 a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $3.52 beat the FactSet consensus of $2.96. Sales grew 17.9% to $1.06 billion, above the FactSet consensus of $985.4 million, with brands lighting and lighting control sales up 18.6% to $1.0 billion and intelligent spaces sales rising 5.2% to $58.3 million. Cost of sales increased 20.0% to $615.5 million, as gross margin contracted to 42.0% from 43.0%. The company said it spent $296 million on share repurchases during the quarter. The stock has dropped 26.4% year to date, while the S&P 500 has shed 19.9%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news......»»

ADP said it's going to halt the release of its private-sector employment report as it retools the report to make it "a more robust, high-frequency view of the labor market and trajectory of economic growth." The report has been criticized for not being a good predictor of what the Labor Department reports in its employment report that is typically issued two days after the ADP survey. ADP says it's targeted August 31, 2022 to reintroduce the new ADP National Employment Report and said it will work with the Stanford Digital Economy Lab on the project.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news......»»

While health regulators debated over how to proceed with developing new booster shots, COVID-19-related hospitalizations and deaths have quietly climbed to new multi-month highs as cases bump up against the top of a six-week range. The seven-day average of new cases rose 7% from two weeks ago to 112,464 on Wednesday, according to a New York Times tracker. The highest reading over the past six weeks was 112,797 on June 7. Big increases in the South, with Arkansas, Mississippi and Alabama seeing cases surge more than 50% in two weeks, offset declines in most Northeast states. The daily average for hospitalizations, which has been rising every day since April 18, rose 9% from two weeks ago to 32,706 on Wednesday, the most since March 9. The daily average for deaths jumped 18% from two weeks ago to 388, the most since April 19.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news......»»

The adjusted unemployment rate was at 5.3% in June, up from 5.0% in May and above the forecast of economists polled by the Journal of 5.0%......»»

Another central bank has hiked interest rates in Europe. Sweden's Riksbank said inflation "prospects remain uncertain.".....»»

If you're a man over 50, you may be wondering whether there's anything special you should be doing for your health. The answer is yes......»»

The German utility scrapped its earnings targets for the year as it struggles to overcome natural gas supply restrictions from Russia......»»

If your kid wants a car, start with some ground rules to establish boundaries. Here are the 'no go zones' to keep your child safe, on track and within budget......»»

You helped them out. But what should you do when they don’t pay you back? Consider these options......»»